Sun Pharma and Philogen sign global licensing agreement for Fibromun
Agreement focuses on global commercialisation of anti-cancer immunotherapy
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Glioblastoma
Zydus gets COFEPRIS nod to market Bhava to treat various cancers
Bhava, a Bevacizumab biosimilar and will be marketed in different strengths of 100 mg/4 ml and 400 mg/16 ml
Trodelvy from Immunomedics gets US FDA orphan drug designation for glioblastoma
Trodelvy has shown encouraging activity in an early-stage study in brain cancers, including partial responses in small cohorts of…
Glioblastoma treatment market will expand five-fold to $3.3 billion by 2024: GlobalData
Japan will see the most impressive relative growth, with sales expanding from $47 million in 2014 to $268 million in 2024